bioLIVE is a unique event within the biopharma industry takes place from 9-11 October at IFEMA in the vibrant city of Madrid. bioLIVE unites biotechs, big pharma and service providers across the whole value chain in large molecules CPhI Offers unparalleled networking opportunities, cost-effective supplier sourcing and a comprehensive content programme. Running adjacent to bioLIVE, at CPhI you can combine business with culture & fun We look forward to meet you at booth number 12c32
The successful concept of biocat is due to an interdisciplinary approach integrating the know-how of highly acknowledged biologists, biochemists, chemists and engineers from academia and industry. Biocat offers a platform to form strategic alliances for future projects and innovations.
The 2018 GRC will feature cutting edge topics in the field, from new forays into the microbiome and into reprogramming synthetic biology, to new classes of natural and semi-synthetic enzymes, to new enzymatic cascades that are being assembled in the laboratory. This frontline biocatalysis research will be admixed with sessions dedicated to fundamental science that will highlight powerful tools now becoming available to the community. These will include in silico methods for engineering physical properties into proteins and emerging techniques in structural biology, such as cryo-electron microscopy (EM) and x-ray free electron laser (XFEL) crystallography, to gain new insight into structure/function, structure/property relationships.
The BIO International Convention is hosted by the Biotechnology Innovation Organization (BIO), which represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations.
Fine chemicals Japan aims to enhance the quality of peoples lives to provide a platform for the exchange of information about the technological innovations and developments in the industries which have strong demand for high-functioning chemicals and to allow participants to create new business opportunities.
ABLE and Biotechnology Industry in India are focused on achieving the $100 billion BioEconomy target by 2025. The current industry size is about $42 billion. The second edition of our BioEconomy India Conclave on March 15-16, 2018 in Bangalore will focus on the theme: How to achieve the $100 billion target by 2025. BioEconomy India Conclave 2018 will identify high growth segments, potential new areas and list the requirement from policy makers, regulators, infrastructure providers, funding agencies and HR institutions to prepare for this future. This 2-day conference will have 12 one-hour sessions, a few Fire Side chats, Key Notes, besides networking and Awards session.
Two day conference jointly organised by DBT and Biofuture platform at Stein auditorium, India Habitat Center, New Delhi. The event brought 400 expert and delegates from 19 countries together in sustainable biofuels sector to take stock of current knowledge, share information and best practices and build consensus on the actions to move forward.
The Enzyme Engineering Conferences were initiated in 1971 and have become the leading international forum for the discussion of new developments in enzyme technology and biocatalysis, putting an emphasis on emerging technologies and focusing on both the fundamental and practical aspects. The proposed scope and thrust of the conference will continue this tradition and will additionally focus on new developments in the field. This conference series typically draws international participation both from industry and academia.